Literature DB >> 29081473

Acute Heart Failure in Patients With Severe Aortic Stenosis - Insights From the CURRENT AS Registry.

Kazuya Nagao1, Tomohiko Taniguchi2, Takeshi Morimoto3, Hiroki Shiomi2, Kenji Ando4, Norio Kanamori5, Koichiro Murata6, Takeshi Kitai7, Yuichi Kawase8, Chisato Izumi9, Makoto Miyake9, Hirokazu Mitsuoka10, Masashi Kato11, Yutaka Hirano12, Shintaro Matsuda2, Tsukasa Inada1, Tomoyuki Murakami13, Yasuyo Takeuchi14, Keiichiro Yamane15, Mamoru Toyofuku16, Mitsuru Ishii17, Eri Minamino-Muta18, Takao Kato18, Moriaki Inoko18, Tomoyuki Ikeda19, Akihiro Komasa20, Katsuhisa Ishii20, Kozo Hotta21, Nobuya Higashitani22, Yoshihiro Kato23, Yasutaka Inuzuka24, Chiyo Maeda25, Toshikazu Jinnai22, Yuko Morikami26, Naritatsu Saito2, Kenji Minatoya27, Takeshi Kimura2.   

Abstract

BACKGROUND: Clinical profiles of acute heart failure (AHF) complicating severe aortic stenosis (AS) remain unclear.Methods and 
Results: From a Japanese multicenter registry enrolling consecutive patients with severe AS, 3,813 patients were categorized into the 3 groups according to the symptom of heart failure (HF); No HF (n=2,210), chronic HF (CHF) (n=813) and AHF defined as hospitalized HF at enrolment (n=790). Median follow-up was 1,123 days with 93% follow-up rate at 2 years. Risk factors for developing AHF included age, female sex, lower body mass index, untreated coronary artery stenosis, anemia, history of HF, left ventricular ejection fraction <50%, presence of any combined valvular disease, peak aortic jet velocity ≥5 m/s and tricuspid regurgitation pressure gradient ≥40 mmHg, and negative risk factors included dyslipidemia, history of percutaneous coronary intervention and hemodialysis. Respective cumulative 5-year incidences of all-cause death and HF hospitalization in No HF, CHF and AHF groups were 37.1%, 41.8% and 61.8% (P<0.001) and 20.7%, 33.8% and 52.3% (P<0.001). Even in the initial aortic valve replacement (AVR) stratum, AHF was associated with excess 5-year mortality risk relative to No HF and CHF (adjusted hazard ratio [HR] 1.64; 95% confidence interval [CI]: 1.14-2.36, P=0.008; adjusted HR 1.47; 95% CI: 1.03-2.11, P=0.03, respectively).
CONCLUSIONS: AHF complicating severe AS was associated with an extremely dismal prognosis, which could not be fully resolved by AVR. Careful management to avoid the development of AHF is crucial.

Entities:  

Keywords:  Acute heart failure; Aortic stenosis; Prognosis

Mesh:

Year:  2017        PMID: 29081473     DOI: 10.1253/circj.CJ-17-0610

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  5 in total

Review 1.  Transcatheter aortic valve replacement in patients with severe aortic stenosis and heart failure.

Authors:  Chirag Bavishi; Dhaval Kolte; Paul C Gordon; J Dawn Abbott
Journal:  Heart Fail Rev       Date:  2018-11       Impact factor: 4.214

2.  Insights into the mechanism of paradoxical low-flow, low-pressure gradient severe aortic stenosis: association with reduced O2 consumption by the whole body.

Authors:  Takeshi Onoue; Mai Iwataki; Masaru Araki; Hideaki Itoh; Akihiro Isotani; Hiromi Umeda; Shota Fukuda; Yasufumi Nagata; Yuki Tsuda; Yoshihisa Fujino; Michiya Hanyu; Kenji Ando; Shinichi Shirai; Masaaki Takeuchi; Satoru Saeki; Robert A Levine; Yutaka Otsuji
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-01-25       Impact factor: 4.733

3.  Outcomes of Emergency Transcatheter Aortic Valve Replacement.

Authors:  Hans Huang; Christopher P Kovach; Sean Bell; Mark Reisman; Gabriel Aldea; James M McCabe; Danny Dvir; Creighton Don
Journal:  J Interv Cardiol       Date:  2019-11-03       Impact factor: 2.279

4.  Efficacy and Safety of Emergent Transcatheter Aortic Valve Implantation in Patients with Acute Decompensated Aortic Stenosis: Systematic Review and Meta-Analysis.

Authors:  Ruochen Shao; Junli Li; Tianyi Qu; Xiaoying Fu; Yanbiao Liao; Mao Chen
Journal:  J Interv Cardiol       Date:  2021-12-24       Impact factor: 2.279

5.  Extracellular Myocardial Volume in Patients With Aortic Stenosis.

Authors:  Russell J Everett; Thomas A Treibel; Miho Fukui; Heesun Lee; Marzia Rigolli; Anvesha Singh; Petra Bijsterveld; Lionel Tastet; Tarique Al Musa; Laura Dobson; Calvin Chin; Gabriella Captur; Sang Yong Om; Stephanie Wiesemann; Vanessa M Ferreira; Stefan K Piechnik; Jeanette Schulz-Menger; Erik B Schelbert; Marie-Annick Clavel; David E Newby; Saul G Myerson; Phillipe Pibarot; Sahmin Lee; João L Cavalcante; Seung-Pyo Lee; Gerry P McCann; John P Greenwood; James C Moon; Marc R Dweck
Journal:  J Am Coll Cardiol       Date:  2020-01-28       Impact factor: 24.094

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.